Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. Guo, L., Zhang, P., Chen, Z., Xia, H., Li, S., Zhang, Y., Kobberup, S., Zou, W., & Lin, J. D Journal of Clinical Investigation, 127(25):1–13, 2017.
doi  bibtex   

Downloads: 0